Successful mRNA COVID-19 vaccination in a patient with a history of severe polyethylene glycol anaphylaxis

BACKGROUND: The mechanism of action behind anaphylactic reactions to the mRNA COVID-19 vaccines remains unknown, but the excipient polyethylene glycol, PEG-2000, has been implicated. Initial recommendations were made for excipient testing with PEG-3350 to help risk stratify individuals and identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Daniel H., Lee, Erika, Song, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208350/
https://www.ncbi.nlm.nih.gov/pubmed/35725661
http://dx.doi.org/10.1186/s13223-022-00698-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208350/
https://www.ncbi.nlm.nih.gov/pubmed/35725661
http://dx.doi.org/10.1186/s13223-022-00698-8

Ejemplares similares